Loading clinical trials...
Loading clinical trials...
Hearing impaired participants will be fit with study devices which will have three different hearing aid programs. Speech intelligibility will be measured using validated tests for each of the three hearing aid programs. The order of the hearing aid programs will be randomized across participants and each participant will be blinded as to the programs being tested.
Program 1 is the current default in the commercially available devices. Programs 2 and 3 are being tested against the current default.
Age
18 - 95 years
Sex
ALL
Healthy Volunteers
No
Phonak Audiology Research Center
Aurora, Illinois, United States
Start Date
April 22, 2025
Primary Completion Date
May 1, 2025
Completion Date
May 1, 2025
Last Updated
May 30, 2025
17
ACTUAL participants
Phonak Audeo Infinio Hearing Aid
DEVICE
Lead Sponsor
Sonova AG
NCT06641999
NCT06642935
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions